Page 11 - Venture Development News Today

2021 has been an interesting year. Mask-wearing, SafeEntry and the changes in phases (we’ve lost count of how many times we’ve entered a new phase) remind us the pandemic hasn’t ended yet. At the same time, looking at the robust property market this year, it doesn’t feel like we’re in a pandemic anymore. Given the positive economic outlook, we’ve seen...

Albuquerque, NM (PRWEB) November 22, 2021 -- Nob Hill Therapeutics (NHT) is pleased to announce the members of its Strategic Advisory Board. Under the

Jerry Adams has long had a vision for a high-tech Arkansas. It's one he's not giving up on even though Adams is now in his late 70s.

BURLINGTON, MA (PRWEB) October 25, 2021 -- Akeso Biomedical, Inc., announced today that the company has obtained authorization in the European Union to market

Aurora, CO (PRWEB) October 14, 2021 -- Neurexis Therapeutics, Incorporated, announces it has been awarded a $496,145 grant from the National Institute of

HĐQT Công ty Cổ phần Phát triển Nhà Thủ Đức - Thuduc House (HoSE: TDH) vừa thông qua chủ trương chuyển nhượng toàn bộ cổ phần tại Công ty Cổ phần Phát triển Nhà Daewon - Thủ Đức.

Georgia Research Alliance Support Enables Production Ramp Up...

NJEDA adds new accelerator to help state-based startups June 3, 2021 1:11 pm The New Jersey Economic Development Authority is adding its third participant to a new incentive program meant to attract and grow startups in the state, known as NJ Accelerate. An accelerator is a type of fixed-term “cohort program,” spanning 15 to 20 weeks, where entrepreneurs are given access to facilities, offices, lab space, seed funding, mentoring and technical assistance to hash out and refine their busin...

In a study that will be published in Nature Communications on May 28, 2021, a research team led by Dr. Yuan Liu from Georgia State University reports that intratumoral SIRPalpha-deficient macrophages activate tumor antigen-specific cytotoxic T cells to eliminate various syngeneic cancers under radiotherapy. Their study identifies SIRPalpha as a master regulator controling macrophage immune responses and has demonstrated that intratumoral injection of SIRPalpha-depleted macrophages combined with ...

VIC Technology Venture Development Announces New Additions to Strategic Advisory Board, Bringing Together Industry Veterans to Guide Medical Innovation Share Article Dr. Dennis Liotta and Dr. Paul Atkins “They are both innovative, life science veterans that have taken impactful technologies from the earliest stage to highly successful exits and we are fortunate to have them on our team.” said Calvin Goforth, Chief Executive Officer of VIC. FAYETTEVILLE, Ark. ...